IVI and Belgium


Belgian Leadership at IVI

From 2013 to 2015, Dr. Georges Thiry served as Deputy Director General of the Portfolio Management Unit.


Ongoing Collaboration

Typhoid Conjugate Vaccine Introduction in Africa program (THECA)

Grant agreement: RIA2017S-2027
Project website

THECA is a consortium led by the University of Cambridge Department of Medicine and funded by a €13 million Euro grant from the European and Developing Countries Clinical Trials Partnership (EDCTP). THECA includes a mass vaccination campaign in the Democratic Republic of the Congo using the Typbar-TCV (Vi-TT) typhoid conjugate vaccine. From 2019-2023, this project will assess the safety, feasibility and cost-effectiveness of Vi-TT and its ability to limit the spread of antimicrobial resistance.

The Institute of Tropical Medicine Antwerp in Belgium is a member of the THECA consortium.